Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy.

[1]  F. Muggia,et al.  Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. , 2001, Journal of the National Cancer Institute.

[2]  P. Ganz,et al.  Making effective use of tumor registries for cancer survivorship research , 2001, Cancer.

[3]  J. Manola,et al.  Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Hayes,et al.  Adjuvant therapy for all patients with breast cancer? , 2001, Journal of the National Cancer Institute.

[5]  M. Sowers.  Lower peak bone mass and its decline. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[6]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[7]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[8]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[9]  M S Calvo,et al.  Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  D. Kiel,et al.  Bone mass and the risk of breast cancer among postmenopausal women. , 1997, The New England journal of medicine.

[11]  S. Cummings,et al.  Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures , 1996 .

[12]  M. Cobleigh,et al.  Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. Burger.  The endocrinology of the menopause. , 1996, Maturitas.

[14]  R. Lindsay,et al.  Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy. , 1976, Israel journal of medical sciences.

[15]  J. Cauley,et al.  Postmenopausal Endogenous and Exogenous Hormones, Degree of Obesity, Thiazide Diuretics, and Risk of Osteoporosis , 2001 .